Stockscreener 앱 받기
149.33
1.39%
-2.11
시간 외 거래:
149.78
0.45
+0.30%
전일 마감가:
$151.44
열려 있는:
$150.89
하루 거래량:
2.01M
Relative Volume:
1.24
시가총액:
$21.89B
수익:
$9.61B
순이익/손실:
$1.53B
주가수익비율:
14.29
EPS:
10.453
순현금흐름:
$1.85B
1주 성능:
+0.13%
1개월 성능:
-6.60%
6개월 성능:
+20.89%
1년 성능:
-13.94%
1일 변동 폭
$149.05
$152.90
1주일 범위
$138.00
$155.33
52주 변동 폭
$110.03
$179.20
Biogen Inc Stock (BIIB) Company Profile
명칭
Biogen Inc
전화
(781) 464-2000
주소
225 BINNEY STREET, CAMBRIDGE, MA
BIIB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIIB
Biogen Inc
|
149.33 | 22.22B | 9.61B | 1.53B | 1.85B | 10.45 |
|
LLY
Lilly Eli Co
|
907.68 | 802.41B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
186.86 | 448.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
216.04 | 374.44B | 59.64B | 2.37B | 18.24B | 1.331 |
|
NVS
Novartis Ag Adr
|
125.01 | 237.66B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
83.86 | 206.04B | 63.99B | 19.05B | 14.72B | 7.5596 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-25 | 개시 | Jefferies | Buy |
| 2025-07-21 | 재개 | Truist | Hold |
| 2025-04-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-04 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-11 | 개시 | Bernstein | Mkt Perform |
| 2025-01-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-11-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-31 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-02-14 | 재확인 | Needham | Buy |
| 2024-02-14 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-01-24 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-12-20 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-12-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-07-24 | 재확인 | UBS | Buy |
| 2023-05-01 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-04-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-26 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-10-13 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-07 | 업그레이드 | Argus | Hold → Buy |
| 2022-09-28 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2022-09-28 | 업그레이드 | Mizuho | Neutral → Buy |
| 2022-09-28 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-04-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-03-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-04 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-04 | 재확인 | Barclays | Equal Weight |
| 2022-02-04 | 재확인 | BofA Securities | Neutral |
| 2022-02-04 | 재확인 | Cowen | Outperform |
| 2022-02-04 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-04 | 재확인 | Needham | Buy |
| 2022-02-04 | 재확인 | Oppenheimer | Outperform |
| 2022-02-04 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-04 | 재확인 | Robert W. Baird | Neutral |
| 2022-02-04 | 재확인 | Wedbush | Neutral |
| 2022-02-04 | 재확인 | Wells Fargo | Equal Weight |
| 2022-02-04 | 재확인 | Wolfe Research | Peer Perform |
| 2022-01-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-01-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 재개 | Raymond James | Mkt Perform |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-06-18 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-06-14 | 재확인 | Truist | Buy |
| 2021-06-11 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2021-06-10 | 업그레이드 | UBS | Neutral → Buy |
| 2021-06-08 | 업그레이드 | Atlantic Equities | Underweight → Neutral |
| 2021-06-08 | 재확인 | Barclays | Equal Weight |
| 2021-06-08 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-06-08 | 재확인 | H.C. Wainwright | Buy |
| 2021-06-08 | 재확인 | Jefferies | Buy |
| 2021-06-08 | 재확인 | Morgan Stanley | Overweight |
| 2021-06-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2021-06-08 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2021-06-08 | 재확인 | Stifel | Buy |
| 2021-06-08 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2021-06-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-06-07 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-06-07 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-02-05 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2021-01-29 | 업그레이드 | Stifel | Hold → Buy |
| 2020-11-10 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-11-09 | 다운그레이드 | Atlantic Equities | Neutral → Underweight |
| 2020-11-09 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-11-09 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-11-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-04 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-11-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-11-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-07-27 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2020-06-22 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-06-22 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2020-06-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-04-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-04-23 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-27 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-12-13 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2019-12-02 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
모두보기
Biogen Inc 주식(BIIB)의 최신 뉴스
Biogen’s yearslong lupus R&D journey could soon pay off - PharmaVoice
Sanford C. Bernstein Forecasts Strong Price Appreciation for Biogen (NASDAQ:BIIB) Stock - MarketBeat
Chart based exit strategy for Biogen Inc.Trade Volume Summary & Growth Focused Investment Plans - newser.com
Recombinant DNA Technology Market Surges with Breakthrough - openPR.com
Biogen Inc. $BIIB Shares Sold by iA Global Asset Management Inc. - MarketBeat
Behavioral Patterns of BIIB and Institutional Flows - news.stocktradersdaily.com
Historical volatility pattern of Biogen Inc. visualized2025 Market Overview & Trade Opportunity Analysis - newser.com
BIIB: Bernstein Raises Price Target for Biogen to $157 with Mark - GuruFocus
Biogen to present felzartamab data at Kidney Week 2025 - Investing.com
Biogen (BIIB) Reveals New Data on Felzartamab at Kidney Week 202 - GuruFocus
Why Biogen Inc. (IDP) stock stays on top picksJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com
Biogen Inc. to Present Groundbreaking Longitudinal Gene Expression Data on Felzartamab at Kidney Week 2025 - Quiver Quantitative
Biogen Inc. $BIIB Shares Bought by State of Michigan Retirement System - MarketBeat
Backtesting results for Biogen Inc. trading strategiesJuly 2025 Price Swings & Short-Term Swing Trade Alerts - newser.com
Plato Investment Management Ltd Raises Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Is Biogen Inc. stock a top momentum playQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
How to escape a deep drawdown in Biogen Inc.Profit Target & Weekly Momentum Stock Picks - newser.com
Using portfolio simulators with Biogen Inc. includedJuly 2025 Gainers & Weekly Return Optimization Alerts - newser.com
FY2025 EPS Estimates for Biogen Decreased by Leerink Partnrs - MarketBeat
Should you wait for a breakout in Biogen Inc.2025 Key Lessons & Smart Money Movement Tracker - newser.com
Amgen Earnings: What To Look For From AMGN - FinancialContent
Is Biogen Inc. stock a safe buy before earningsRisk Management & High Conviction Trade Alerts - newser.com
Biogen (NASDAQ:BIIB) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Guggenheim Increases Biogen (NASDAQ:BIIB) Price Target to $185.00 - MarketBeat
Biogen (NASDAQ:BIIB) Given New $150.00 Price Target at BMO Capital Markets - MarketBeat
Biogen (NASDAQ:BIIB) Price Target Raised to $143.00 - MarketBeat
Biotech Investments Market Seeking Excellent Growth | Biogen (US), Moderna, Johnson & Johnson - openPR.com
How a Strong Q3 and Increased R&D Spending at Biogen (BIIB) Has Changed Its Investment Story - simplywall.st
Biogen shares drop as full-year guidance cut outweighs strong Q3 results - MSN
Institutional scanner results for Biogen Inc.2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Published on: 2025-11-02 04:50:47 - newser.com
Savvy Advisors Inc. Buys New Holdings in Biogen Inc. $BIIB - MarketBeat
Biogen Inc. $BIIB Stock Holdings Increased by Wealthfront Advisers LLC - MarketBeat
Sector ETF performance correlation with Biogen Inc.July 2025 Retail & Safe Swing Trade Setups - newser.com
Biogen (NASDAQ:BIIB) Stock Rating Lowered by Wall Street Zen - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Q3 2025 Earnings Call Transcript - Insider Monkey
Biogen’s Earnings Call Highlights Robust Growth and Positive Outlook - The Globe and Mail
Key metrics from Biogen Inc.’s quarterly dataWeekly Profit Recap & Precise Swing Trade Entry Alerts - newser.com
Royal Bank Of Canada Lowers Biogen (NASDAQ:BIIB) Price Target to $210.00 - MarketBeat
Biogen (NASDAQ:BIIB) Price Target Cut to $250.00 by Analysts at Robert W. Baird - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Option Care Health (OPCH) and Amneal Pharmaceuticals (AMRX) - The Globe and Mail
Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results - MSN
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $3.44 Million Stake in Biogen Inc. $BIIB - MarketBeat
Analyzing Biogen Inc. with multi timeframe chartsTrade Volume Summary & Long-Term Growth Plans - newser.com
Biogen Inc. Reports Strong Q3 2025 Results - The Globe and Mail
Biogen (NASDAQ:BIIB) Issues Earnings Results - MarketBeat
BMO Capital Adjusts Biogen Price Target to $150 From $128 - MarketScreener
Biogen (BIIB) Rating Maintained as RBC Capital Lowers Price Targ - GuruFocus
BIIB Q3 Deep Dive: New Product Launches Offset Guidance Cut, R&D Pipeline Expands - Yahoo Finance
Wedbush Raises Price Target on Biogen to $143 From $135, Keeps Neutral Rating - MarketScreener
Wells Fargo Adjusts Price Target on Biogen to $155 From $140 - MarketScreener
Biogen Inc (BIIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.88%
0.81%
자본화:
|
볼륨(24시간):